World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
45
Citations
9142
World Ranking
4687
National Ranking
2115

Andrew H. Talal publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andrew H. Talal sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 186 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Andrew H. Talal D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew H. Talal sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 45 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Andrew H. Talal is affiliated with the University at Buffalo, State University of New York in the United States. Their research focuses on medical and health-related fields, with a predominant concentration in hepatology and epidemiology.

The scholar has published extensively in the following main fields and subfields of study:

  • Medicine
  • Hepatology
  • Epidemiology
  • Family Practice
  • Public Health, Environmental and Occupational Health
  • General Health Professions

Talal's main research topics include:

  • Hepatitis C virus research
  • HIV, Drug Use, Sexual Risk
  • Medication Adherence and Compliance
  • Liver Disease Diagnosis and Treatment
  • Telemedicine and Telehealth Implementation
  • Mobile Health and mHealth Applications
  • Hepatitis B Virus Studies

Frequent coauthors in Talal's academic work are:

  • Arpan Dharia
  • Marianthi Markatou
  • Suzanne S. Dickerson
  • Lawrence S. Brown
  • Elaine Wethington

Talal publishes regularly in a range of scientific journals, including:

  • Journal of Hepatology
  • Journal of Viral Hepatitis
  • Telemedicine Journal and e-Health
  • Journal of Medical Internet Research
  • PLoS ONE

Some of Talal's recent papers include:

  • "A framework for patient-centered telemedicine: Application and lessons learned from vulnerable populations" (2020, Journal of Biomedical Informatics)
  • "Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine" (2024, JAMA)
  • "Hepatitis C Treatment Initiation Among US Medicaid Enrollees" (2023, JAMA Network Open)
  • "Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C)" (2021, Contemporary Clinical Trials)
  • "High Satisfaction with Patient-Centered Telemedicine for Hepatitis C Virus Delivered to Substance Users: A Mixed-Methods Study" (2022, Telemedicine Journal and e-Health)

Their work notably addresses telemedicine approaches in hepatitis C care, integrating opioid use disorder treatments and patient adherence issues. The research outputs include both clinical trial reports and studies examining patient satisfaction and healthcare delivery frameworks focused on vulnerable populations.

Best Publications

  • Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

    Linqi Zhang;B. Ramratnam;K. Tenner-Racz;Yuxian He

  • Neutralizing antibody response during acute and chronic hepatitis C virus infection

    Carine Logvinoff;M E Major;D Oldach;S Heyward

  • Hepatitis C virus infection in USA: an estimate of true prevalence

    Eric W Chak;Andrew H. Talal;Kenneth E. Sherman;Eugene R. Schiff

  • NATURALLY OCCURRING DOMINANT RESISTANCE MUTATIONS TO HEPATITIS C VIRUS PROTEASE AND POLYMERASE INHIBITORS IN TREATMENT-NAIVE PATIENTS

    Thomas Kuntzen;Joerg Timm;Andrew Berical;Niall Lennon

  • Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C†

    Marija Zeremski;Lydia M. Petrovic;Luis Chiriboga;Queenie B. Brown

  • In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5

    Linqi Zhang;Tian He;Andrew Talal;Gloria Wang

  • The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection

    M. Zeremski;L. M. Petrovic;A. H. Talal

  • Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

    Edgar D. Charles;Edgar D. Charles;Claudia Brunetti;Claudia Brunetti;Svetlana Marukian;Kimberly D. Ritola

  • The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune Responses

    Martin Markowitz;Mika Vesanen;Klara Tenner-Racz;Yunzhen Cao

  • Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C

    David Butera;Svetlana Marukian;Amy E. Iwamaye;Edgardo Hembrador

  • Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

    Etienne Patin;Etienne Patin;Zoltán Kutalik;Zoltán Kutalik;Julien Guergnon;Stéphanie Bibert

  • Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia

    Edgar D. Charles;Edgar D. Charles;Rashidah M. Green;Svetlana Marukian;Andrew H. Talal

  • Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.

    Randy S. Longman;Andrew H. Talal;Andrew H. Talal;Andrew H. Talal;Ira M. Jacobson;Ira M. Jacobson;Ira M. Jacobson;Matthew L. Albert;Matthew L. Albert;Matthew L. Albert

  • Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis

    Rositsa B. Dimova;Marija Zeremski;Ira M. Jacobson;Holly Hagan

  • Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C

    Randy S. Longman;Randy S. Longman;Randy S. Longman;Andrew H. Talal;Ira M. Jacobson;Charles M. Rice

  • The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States

    Mark H. Eckman;Andrew H. Talal;Stuart C. Gordon;Eugene Schiff

  • Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing.

    A H Talal;J A Murray;J A Goeken;W I Sivitz

  • Peripheral CXCR3-Associated Chemokines as Biomarkers of Fibrosis in Chronic Hepatitis C Virus Infection

    Marija Zeremski;Rositsa Dimova;Queenie Brown;Ira M. Jacobson

  • The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

    N. H. Afdhal;S. Zeuzem;R. T. Schooley;D. L. Thomas

  • Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care

    Marija Zeremski;Jon E Zibbell;Anthony D Martinez;Steven Kritz

Frequent Co-Authors

Ira M. Jacobson
Ira M. Jacobson New York University
Charles M. Rice
Charles M. Rice Rockefeller University
Brian R. Edlin
Brian R. Edlin National Development and Research Institutes
Alan S. Perelson
Alan S. Perelson Los Alamos National Laboratory
Ruy M. Ribeiro
Ruy M. Ribeiro Los Alamos National Laboratory
Don C. Des Jarlais
Don C. Des Jarlais New York University
David D. Ho
David D. Ho Columbia University
Douglas T. Dieterich
Douglas T. Dieterich Icahn School of Medicine at Mount Sinai
Laurent Abel
Laurent Abel Université Paris Cité
Michael P. Busch
Michael P. Busch University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens doors to a variety of healthcare careers, especially in nursing and specialized practitioner roles. For those interested in clinical practice, exploring the easiest LPN programs to get into can offer a streamlined entry into patient care. These programs provide foundational nursing skills applicable in many medical settings.

Advancing further, aspiring healthcare professionals might consider Nurse Practitioner degrees. Some candidates prefer programs that balance quality and accessibility, such as those listed under easiest NP programs to get into. These options can help mitigate common admission barriers while maintaining strong clinical training.

Specializing in mental health is another promising pathway, particularly through becoming a Psychiatric Mental Health Nurse Practitioner (PMHNP). When choosing a program, clinical placements are crucial. The best online psychiatric mental health nurse practitioner programs offer excellent hands-on experience, vital for career success.

Cost also plays a significant role in education decisions. Prospective students looking for budget-friendly options can explore the cheapest PMHNP programs online, which provide affordable routes to specialized nursing credentials without compromising educational quality.

Best Scientists Citing Andrew H. Talal

Trending Scientists

Recently Published Articles